$7.03 Billion is the total value of C WorldWide Group Holding A/S's 165 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NLNK | Exit | NEWLINK GENETICS CORP | $0 | – | -9,980 | -100.0% | -0.00% | – |
TSS | Exit | TOTAL SYS SVCS INC | $0 | – | -10,300 | -100.0% | -0.01% | – |
CCI | Exit | CROWN CASTLE INTL CORP NEW | $0 | – | -6,085 | -100.0% | -0.01% | – |
CVX | Exit | CHEVRON CORP NEW | $0 | – | -7,700 | -100.0% | -0.01% | – |
CEMP | Exit | CEMPRA INC | $0 | – | -592,946 | -100.0% | -0.04% | – |
Exit | NEURODERM LTD | $0 | – | -92,800 | -100.0% | -0.04% | – | |
SPNC | Exit | SPECTRANETICS CORP | $0 | – | -73,180 | -100.0% | -0.04% | – |
KITE | Exit | KITE PHARMA INC | $0 | – | -58,443 | -100.0% | -0.09% | – |
NKE | Exit | NIKE INCcl b | $0 | – | -190,523 | -100.0% | -0.17% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-06
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VISA INC | 37 | Q3 2023 | 15.5% |
THERMO FISHER SCIENTIFIC INC | 37 | Q3 2023 | 11.2% |
HDFC BANK LTD | 37 | Q3 2023 | 3.7% |
ICICI BK LTD | 37 | Q3 2023 | 2.1% |
CENTENE CORP DEL | 37 | Q3 2023 | 0.4% |
DEX INC | 37 | Q3 2023 | 0.5% |
BIOMARIN PHARMACEUTICAL INC | 37 | Q3 2023 | 0.3% |
VERTEX PHARMACEUTICALS INC | 37 | Q3 2023 | 0.4% |
INSULET CORP | 37 | Q3 2023 | 0.3% |
CARA THERAPEUTICS INC | 37 | Q3 2023 | 0.2% |
View C WorldWide Group Holding A/S's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-03 |
13F-HR | 2024-02-05 |
13F-HR | 2023-11-03 |
13F-HR | 2023-08-02 |
13F-HR | 2023-05-02 |
13F-HR | 2023-02-03 |
13F-HR | 2022-11-03 |
13F-HR | 2022-08-02 |
13F-HR | 2022-05-04 |
13F-HR | 2022-02-02 |
View C WorldWide Group Holding A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.